BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.12.24 | Real-time Boerse Frankfurt Warrants 08:24:22 03/06/2024 pm IST | ||
| 0.96 EUR | +17.07% |
|
| 1 month | -31.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 0.96 | +17.07% |
| 31/24/31 | 0.82 | -13.68% |
| 30/24/30 | 0.95 | +10.47% |
| 29/24/29 | 0.86 | +1.18% |
| 28/24/28 | 0.85 | -20.56% |
Real-time Boerse Frankfurt Warrants
Last update June 03, 2024 at 08:24 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VD3SE8 |
| ISIN | DE000VD3SE89 |
| Date issued | 09/04/2024 |
| Strike | 125 $ |
| Maturity | 20/12/2024 (200 Days) |
| Parity | 10 : 1 |
| Emission price | 1.04 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.35 € |
|---|---|
| Lowest since issue | 0.82 € |
| Spread | 0.01 € |
| Spread % | 1.01% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Warrants
- Warrant
